Meade was one of four UPMC leaders who participated in the “Women in Healthcare Leadership” panel discussion that was organized by FLIGHT – Female Leadership, Innovation, and Growth in Healthcare & Technology – a UPMC Enterprises group established to create mentorship and networking opportunities for women.
Can you provide an example of a time you took action to grab an opportunity that others may have overlooked you for, and how you made it happen?
I believe strongly that you must ask for opportunities. Data show that women (traditionally) are less likely to advocate for themselves or to ask for advancement. Just ask—what is the worst thing that could happen? While I could provide examples of where I “advocated” for my advancement, this approach has multiple faces. When I was pregnant with my first child I went to the global head of my practice and asked if there was any way I could materially limit my travel after the baby came. I was at a firm where travel was a fundamental expectation of the job. I fully expected him to demur and for me to leave. But he created a new role for me which allowed me to flex my schedule enough to continue my career. I stayed at that firm for an additional six years (and two additional babies). I remember being very hesitant to ask for that “exception” — but I wonder where I’d be if I hadn’t.
How do you handle the day-to-day responsibilities of being a leader to your team AND getting your work done?
Long hours. I wish I had something more inspirational to say but it is the reality. I try my best to balance long hours one night and then get home for dinner the next to ensure there is still balance in my life.
About Alissa Meade
Alissa Meade is the current President and CEO of Curavi Health. Prior to Curavi, Alissa held positions with UPMC Enterprises, UPMC Health Plan, management consulting firm McKinsey & Co., and investment banking firm Citi. She received a J.D. and LL.M. from Duke University, where she was on Duke Law Review, and a B.A. in International Relations and French, with honors, from Miami University.
UPMC Enterprises announces $1 billion commitment to life sciences investments
The Translational Sciences team at UPMC Enterprises will be investing $1 billion by 2024 to develop new drugs, diagnostics, and devices.
Meet the Executive: Wendy Zellner, Vice President of Public Relations at UPMC
At UPMC, Zellner helps to oversee UPMC’s roughly 15-person media group (covering UPMC and Pitt Schools of the Health Sciences), and personally works with UPMC’s Enterprises, International, Information Services, and Quality divisions to identify and tell the organizations’ best stories to the media.